American International Group’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-86,593
Closed -$62K 3088
2022
Q1
$62K Sell
86,593
-6,095
-7% -$4.36K ﹤0.01% 2769
2021
Q4
$209K Sell
92,688
-2,773
-3% -$6.25K ﹤0.01% 2342
2021
Q3
$275K Buy
95,461
+5,923
+7% +$17.1K ﹤0.01% 2228
2021
Q2
$339 Buy
89,538
+6,066
+7% +$23 ﹤0.01% 2174
2021
Q1
$283 Buy
83,472
+220
+0.3% +$1 ﹤0.01% 2171
2020
Q4
$233 Sell
83,252
-2,388
-3% -$7 ﹤0.01% 2198
2020
Q3
$215K Buy
85,640
+6,029
+8% +$15.1K ﹤0.01% 2102
2020
Q2
$1.08M Buy
79,611
+9,724
+14% +$132K 0.01% 1179
2020
Q1
$530K Sell
69,887
-4,039
-5% -$30.6K ﹤0.01% 1399
2019
Q4
$467K Sell
73,926
-622
-0.8% -$3.93K ﹤0.01% 1726
2019
Q3
$292K Sell
74,548
-520
-0.7% -$2.04K ﹤0.01% 1948
2019
Q2
$363K Buy
75,068
+20,354
+37% +$98.4K ﹤0.01% 1884
2019
Q1
$448K Sell
54,714
-1,772
-3% -$14.5K ﹤0.01% 1777
2018
Q4
$312K Buy
56,486
+23,038
+69% +$127K ﹤0.01% 1927
2018
Q3
$295K Buy
33,448
+602
+2% +$5.31K ﹤0.01% 2182
2018
Q2
$328K Buy
32,846
+4,233
+15% +$42.3K ﹤0.01% 2089
2018
Q1
$273K Sell
28,613
-1,538
-5% -$14.7K ﹤0.01% 2080
2017
Q4
$448K Buy
30,151
+431
+1% +$6.4K ﹤0.01% 1853
2017
Q3
$585K Buy
29,720
+6,836
+30% +$135K ﹤0.01% 1659
2017
Q2
$329K Buy
22,884
+763
+3% +$11K ﹤0.01% 1978
2017
Q1
$204K Buy
22,121
+1,460
+7% +$13.5K ﹤0.01% 2170
2016
Q4
$215K Sell
20,661
-54
-0.3% -$562 ﹤0.01% 2132
2016
Q3
$187K Buy
20,715
+31
+0.1% +$281 ﹤0.01% 2210
2016
Q2
$155K Buy
20,684
+6,405
+45% +$47.9K ﹤0.01% 2321
2016
Q1
$129K Hold
14,279
﹤0.01% 3191
2015
Q4
$184K Sell
14,279
-25
-0.2% -$322 ﹤0.01% 2930
2015
Q3
$138K Buy
14,304
+17
+0.1% +$164 ﹤0.01% 3157
2015
Q2
$147K Buy
14,287
+9,361
+190% +$96.3K ﹤0.01% 3310
2015
Q1
$54.7K Hold
4,926
﹤0.01% 3922
2014
Q4
$57.3K Sell
4,926
-195
-4% -$2.27K ﹤0.01% 3907
2014
Q3
$113K Sell
5,121
-3
-0.1% -$66 ﹤0.01% 3448
2014
Q2
$142K Buy
+5,124
New +$142K ﹤0.01% 3296